Detail akcie Champns Onclgy online

Business Summary: Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Financial Summary: BRIEF: For the six months ended 31 October 2025, Champions Oncology Inc revenues increased 5% to $29M. Net loss totaled $168K vs. income of $2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects research and development increase of 48% to $4.6M (expense), general and administratiojn increase of 20% to $5.2M (expense).